Effects of quetiapine extended release on sleep and quality of life in midlife women with major depressive disorder

Archives of Women's Mental Health

Volumn 16, Issue 1, 2013, Pages 83-85

  Frey, Benicio N ^a,b   Haber, Erika ^a   Mendes, Gustavo C D ^c   Steiner, Meir ^a,b   Soares, Claudio N ^a  

^a Women's Health Concerns Clinic   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Depression; Menopause transition; Quality of life; Quetiapine XR; Sleep

Indexed keywords

PLACEBO; QUETIAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GREENE CLIMACTERIC SCALE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR DEPRESSION; MENOPAUSE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PITTSBURGH INSOMNIA RATING SCALE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SLEEP DISORDER; SLEEP PARAMETERS; SUSTAINED DRUG RELEASE; SYMPTOMATOLOGY;

ADULT; ANTIPSYCHOTIC AGENTS; CANADA; DELAYED-ACTION PREPARATIONS; DEPRESSIVE DISORDER, MAJOR; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; QUALITY OF LIFE; SINGLE-BLIND METHOD; SLEEP; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 84872612682     PISSN: 14341816     EISSN: 14351102     Source Type: Journal    
DOI: 10.1007/s00737-012-0314-y     Document Type: Article

References (20)

1. Bolge SC, Balkrishnan R, Kannan H, Seal B, Drake CL (2010) Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms. Menopause 17:80-86
2. Diehr PH, Derleth AM, McKenna SP, Martin ML, Bushnell DM et al (2006) Synchrony of change in depressive symptoms, health status, and quality of life in persons with clinical depression. Health Qual Life Outcomes 4:27 (Pubitemid 44150673)
3. Greene JG (1998) Constructing a standard climacteric scale. Maturitas 29:25-31 (Pubitemid 28247565)
4. Harvey AG (2011) Sleep and circadian functioning: critical mechanisms in the mood disorders? Annu Rev Clin Psychol 7:297-319
5. Hilditch JR, Lewis J, Peter A, van Maris B, Ross A et al (1996) A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 24:161-175
6. Ishak WW, Ha K, Kapitanski N, Bagot K, Fathy H et al (2011) The impact of psychotherapy, pharmacotherapy, and their combination on quality of life in depression. Harv Rev Psychiatry 19:277-289
7. Joffe H, Soares CN, Petrillo LF, Viguera AC, Somley BL et al (2007) Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. J Clin Psychiatry 68:943-950 (Pubitemid 47015497)
8. Moul DE, Pilkonis PA, Miewald JM, Carey TJ, Buysse DJ (2002) Preliminary study of the test-retest reliability and concurrent validities of the Pittsburgh Insomnia Rating Scale (PIRS). Sleep 25:A246-A247
9. Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M (2004) Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry 26:13-17 (Pubitemid 38142561)
10. Perlis ML, Giles DE, Buysse DJ, Tu X, Kupfer DJ (1997) Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 42:209-212 (Pubitemid 27170166)
11. Pillai V, Kalmbach DA, Ciesla JA (2011) A meta-analysis of electroencephalographic sleep in depression: evidence for genetic biomarkers. Biol Psychiatry 70:912-919
12. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(20):22-33, quiz 4-57 (Pubitemid 29001829)
13. Soares CN (2005) Insomnia in women: an overlooked epidemic? Arch Women Ment Health 8:205-213 (Pubitemid 41618840)
14. Soares CN, Arsenio H, Joffe H, Bankier B, Cassano P et al (2006) Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause 13:780-786 (Pubitemid 44435032)
15. Soares CN, Frey BN, Haber E, Steiner M (2010) A pilot, 8-week, placebo lead-in trial of quetiapine extended release for depression in midlife women: impact on mood and menopause-related symptoms. J Clin Psychopharmacol 30:612-615
16. Soares CN, Murray BJ (2006) Sleep disorders in women: clinical evidence and treatment strategies. Psychiatr Clin North Am 29:1095-1113, abstract xi (Pubitemid 44751926)
17. Soares CN, Zitek B (2008) Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci 33:331-343 (Pubitemid 351977159)
18. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N et al (2001) Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 76:874-878 (Pubitemid 33031310)
19. Van Londen L, Molenaar RP, Goekoop JG, Zwinderman AH, Rooijmans HG (1998) Three- to 5-year prospective follow-up of outcome in major depression. Psychol Med 28:731-735 (Pubitemid 28241305)
20. Williams RE, Levine KB, Kalilani L, Lewis J, Clark RV (2009) Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life. Maturitas 62:153-159